Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-26 4:57 pm Purchase | 13D | SAVARA INC SVRA | Growth Equity Opportunities 17 LLC | 24,471,264 18.1% | 333,333 (+1.38%) | View |
| 2023-05-02 5:26 pm Sale | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | Growth Equity Opportunities 17 LLC | 0 0% | -2,488,587 (Position Closed) | View |
| 2023-02-03 5:27 pm Sale | 13D | GERON CORP GERN | Growth Equity Opportunities 17 LLC | 0 0% | -20,192,307 (Position Closed) | View |
| 2023-01-27 4:58 pm Sale | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | Growth Equity Opportunities 17 LLC | 2,488,587 7.5% | -504,371 (-16.85%) | View |
| 2022-08-12 5:15 pm Sale | 13D | VISTAGEN THERAPEUTICS, INC. CO VTGN | Growth Equity Opportunities 17 LLC | 0 0% | -16,302,596 (Position Closed) | View |
| 2021-04-29 10:17 am Purchase | 13D | VISTAGEN THERAPEUTICS, INC. CO VTGN | Growth Equity Opportunities 17 LLC | 16,302,596 8.6% | 6,942,596 (+74.17%) | View |
| 2021-03-25 5:10 pm Purchase | 13D | SAVARA INC SVRA | Growth Equity Opportunities 17 LLC | 24,137,931 24.2% | 24,137,931 (New Position) | View |
| 2021-03-15 2:52 pm Purchase | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | Growth Equity Opportunities 17 LLC | 2,992,958 9.5% | 2,992,958 (New Position) | View |
| 2021-01-04 06:00 am Purchase | 13D | VISTAGEN THERAPEUTICS, INC. CO VTGN | Growth Equity Opportunities 17 LLC | 9,360,000 6.8% | 9,360,000 (New Position) | View |
| 2020-06-04 2:58 pm Purchase | 13D | GERON CORP GERN | Growth Equity Opportunities 17 LLC | 20,192,307 9.6% | 20,192,307 (New Position) | View |